पहचान

Ormeloxifene Impurity 1

सूचीबद्ध नहीं · C30H35NO3

01पहचान

Lazychem IDLC-48783
CAS RNसूचीबद्ध नहीं
PubChem CID5745291
Molecular formulaC30H35NO3
Molecular weight457.6 g/mol
IUPAC name1-[2-[4-[(3S,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydrochromen-4-yl]phenoxy]ethyl]pyrrolidine
InChIKeyXZEUAXYWNKYKPL-FQLXRVMXSA-N

02संरचना और त्रिविम रसायन

2D structurePubChem CID 5745291
Two-dimensional chemical structure of Ormeloxifene Impurity 1
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 2 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres2
Ring count5
Secondary amines0
Tertiary amines1
SMILESCC1([C@@H]([C@@H](C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C
InChIसूचीबद्ध नहीं

03Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres2Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04भारत में स्थिति

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05नाम और संबंध

API और मूल औषधि

सूचीबद्ध नहीं

नाम और संबंध

    अशुद्धियाँ और संबंधित यौगिक

      06स्रोत